Hubbard Logan, Rambhatla Amarnath, Colpi Giovanni M
Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI 48202-3450, USA.
Andrology and IVF Center, Next Fertility Procrea, Lugano 6900, Switzerland.
Asian J Androl. 2025 May 1;27(3):298-306. doi: 10.4103/aja202475. Epub 2024 Sep 13.
Male infertility has seen an increase in prevalence with cases of azoospermia estimated to affect 10%-15% of infertile men. Confirmation of azoospermia subsequently necessitates an early causal differentiation between obstructive azoospermia (OA) and nonobstructive azoospermia (NOA). Although less common when compared to NOA, OA can represent upward 20%-40% of cases of azoospermia. While there are a multitude of etiologies responsible for causing NOA and OA, correctly distinguishing between the two types of azoospermia has profound implications in managing the infertile male. This review represents an amalgamation of the current guidelines and literature which will supply the reproductive physician with a diagnostic armamentarium to properly distinguish between NOA and OA, therefore providing the best possible care to the infertile couple.
男性不育症的患病率呈上升趋势,据估计,无精子症病例影响10%-15%的不育男性。确诊无精子症后,随后需要尽早区分梗阻性无精子症(OA)和非梗阻性无精子症(NOA)的病因。与NOA相比,OA虽然不太常见,但可占无精子症病例的20%-40%。虽然导致NOA和OA的病因众多,但正确区分这两种类型的无精子症对不育男性的治疗具有深远意义。本综述整合了当前的指南和文献,将为生殖科医生提供诊断工具,以正确区分NOA和OA,从而为不育夫妇提供尽可能最佳的治疗。